Molecular network of obesity: what does it promise for pharmacotherapy?

M Myslobodsky1

  • 1Howard University Graduate School, Washington, DC and Clinical Brain Disorders Branch, NIMH/National Institutes of Health, Bethesda, MD 20892-1379, USA. myslobom@mail.nih.gov

Insights

Receptors for appetite signals also influence cognitive and motor functions. Their modular organization explains how these signals control both appetite and non-appetitive behaviors, aiding therapeutic interventions.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Systems Biology

Background:

  • Growing evidence links orexigenic and anorexigenic neuropeptide receptors to diverse functions beyond appetite.
  • These receptors are involved in cognitive, emotional, sensory, and motor processes.
  • The precise mechanisms by which appetite signals influence non-appetitive behaviors remain unclear.

Purpose of the Study:

  • To explore the modular organization of neuropeptide signaling pathways.
  • To understand how these pathways regulate both appetitive and non-appetitive behaviors.
  • To inform pharmacotherapeutic strategies by considering the widespread effects of related agents.

Main Methods:

  • This study is a perspective piece, synthesizing existing evidence.
  • It proposes a framework based on network analysis.
  • Focuses on the modular organization of signaling networks.

Main Results:

  • Receptor systems for appetite signals possess a modular architecture.
  • Each module, while part of appetite control networks, is also engaged in distinct functional domains.
  • This organization explains the dual role in appetitive and non-appetitive behaviors.

Conclusions:

  • The modular organization of appetite-related neuropeptide receptors is key to their diverse functions.
  • Network analysis is crucial for understanding these complex interactions.
  • This perspective aids in predicting and mitigating central side effects of therapeutic agents targeting these pathways.

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...